9939 — Kintor Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$750.48m
- HK$870.57m
- CNY32.68m
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint
Brief: Kintor Pharmaceutical's Unit Enters Into Cooperation Agreement With Zhejiang Fonuw Medicine
Brief: Kintor Pharmaceutical Says Chairman Buys By 4.7 MLN Co Shares For HK$10.82 MLN From Nov 17, 2025 To Jan 23
Brief: Kintor Pharmaceutical Enters Exclusive Sales Agency Agreement For Anti-Hair Loss Foam Product
Brief: Kintor Pharmaceutical To Allot And Issue Aggregate 30.5 Mln Shares At HK$1.64 Per Share
Brief: Kintor Pharmaceutical To Issue 20.7 MLN Shares For HK$2.08 Per Share
Brief: Kintor Pharmaceutical Announces Stepping down of Dr. Youzhi Tong As Chairman
Brief: Kintor Pharmaceutical Says Unit Entered Brand And Sales Operation Cooperation Agreement
Brief: Kintor Pharmaceutical Says CEO Bought 995,500 Shares Of Co In Open Market
Brief: Kintor Pharmaceutical Says Clinical Trial Of Kx-826 Tincture 1.0% Cleared By NMPA
Brief: Kintor Pharmaceutical Announces Return Of Land Use Right In Pinhu, Zhejiang, PRC
Brief: Kintor Pharmaceutical Posts FY Loss Before Income Tax Of Rmb1.07 Bln
Brief: Kintor Pharmaceutical Says Results Of Kx-826 Phase III Clinical Trial In China
Brief: Kintor Pharma Completes First Patient Enrollment In Long-Term Safety Trial Of AGA Treatment KX-826
Brief: Kintor Pharmaceutical Says Successful Completion Of Phase Ii Clinical Trial Of Kx-826
Brief: Kintor Pharmaceutical Says Qun Lu And Xiang Ni Appointed As Executive Directors